Clinical Trial Update: Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease [Phase 2]

View source ↗

Summary

Phase 2 efficacy and safety results from NV1FGF in patients with severe peripheral arterial disease have been completed. The update summarizes the study outcome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• NV1FGF (NV1FGF)

Snippet

Sponsor: Sanofi | Conditions: Peripheral Arterial Disease | Phase 2 | Status: COMPLETED